您的位置: 首页 > 农业专利 > 详情页

lrrk2 kinase activity inhibitors
专利权人:
INC.;ELAN PHARMACEUTICALS
发明人:
ALBERT W. GAROFALO,ANH P.TRUONG,DANIELLE L. AUBELE,GARY PROBST,MARC ADLER,MAURIZIO FRANZINI,R. JEFFREY NIETZ,SIMEON BOWERS,XIAOCONG MICHAEL YE
申请号:
BR112013030095
公开号:
BR112013030095A2
申请日:
2012.05.21
申请国别(地区):
BR
年份:
2019
代理人:
摘要:
The present invention provides compounds having a structure according to Formula I: (I) or a salt or solvate thereof, wherein R1, R2, R3 and R4 are defined herein. The invention further provides pharmaceutical compositions including the compounds of the invention and methods of making and using the compounds and compositions of the invention, e.g., in the treatment and prevention of various disorders, such as Parkinson's disease.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充